PACTR202305870625335

Combined Adductor Canal and Infiltration in the Space between Popliteal Artery and Posterior Capsule of the Knee Blocks (IPACK) Versus Combined Genicular Nerve Block and Infiltration in the Space between Popliteal Artery and Posterior Capsule of the Knee Block (IPACK) in Total Knee Arthroplasty.

Sara Magdy Abdelrhman Elkfafi·Not Applicable·Pan Africa Clinical Trials RegistryNot yet recruiting
Study focus
Disease/Condition
Anaesthesia
Sponsor & location
Primary sponsor
Sara Magdy Abdelrhman Elkfafi
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 2023
End date
Jan 01, 1900
Summary

Optimal postoperative knee analgesia is important for not only patient comfort and satisfaction, but also for accelerating mobilization, functional recovery, and hospital discharge. Multimodal analgesia and motor-protective blocks are increasingly used to facilitate early ambulation and provide superior performance .The comparison of combined ACB and IPACK blocks versus combined GNB and IPACK blocks as analgesia for TKA is currently lacking in the anaesthesia literatures, thus this study compares the combination of ACB with IPACK blocks versus the combination of GNB with IPACK blocks regarding providing superior analgesia and limiting motor weakness. Also improving postoperative pain score, ambulation, and oral morphine equivalents

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsOther complications of anaesthesiaLocal anaestheticsAnaesthesia of skin
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202305870625335
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202305870625335 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sara Magdy Abdelrhman Elkfafi and is currently Not yet recruiting. The study focuses on Anaesthesia.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.